Hypertension Flashcards
normal BP
<80
pre hypertension
120-139/80-89
stage I HTN
140-159/90-99
stage II HTN
> 160/>100
which drugs can cause secondary HTN
corticosteroids, anorexiants/decongestants, thyroid hormone excess, OCPs, NSAIDs/COX-2, occasionally TCA’s and venlafaxine, excessive licorice
goal BP- no diabetes, no kidney diseases
<140/90
goal BP- diabetes or kidney disease
<130/80
first choice patient with stage I HTN without compelling indications
Thiazide
first choice for patient with stage II HTN without compelling indications
2 drug combo: ACEI, ARB, BB, or CCB
first choice HTN tx pt has heart failure
ACEI plus BB
first choice HTN tx pt has CAD
ACEI plus BB
first choice HTN tx pt has diabetes
ACEI or ARB
first choice HTN tx pt has CKD
ACEI or ARB
first choice HTN tx pt has recurrent stroke
ACEI plus thiazide
first choice HTN tx pt has isolated systolic HTN
thiazide
what does excessive body sodium do in the body
increases vascular resistance (increases vessel rigidity, fluid retention, and epi and norepi release
this diuretic has a potent diuretic effect but low hypertensive effect
furosemide
this class inhibits luminal NaCl transport in the distal tubule of the kidney
thiazide
short term effects: sodium and water excretion (decreases plasma volume)
HCTZ
long term effects: decrease peripheral vascular resistance
HCTZ
this class loses efficacy as renal function declines, not generally used if creat clearance is <30 mL/min
thiazide diuretics
can use this class for HTN, CHF, nephrogenic diabetes insipidus, and to prevent kidney stones due to hypercalciuria
thiazide diuretics
Adverse effects: HYPOkalemia, hyperuricemia, hypomagnesemia, impaired carb tolerance, and HYPERglycemia
thiazide
this class changes urine ionic content: increases the loss of Na, K, and water
thiazide
adverse effects: hyperlipidemia, hyponatremia (our goal), allergies, weakness, fatigue, parasthesias, impotence, photosensitivity
thiazide
this drug is usually combined with loop diuretics for patients with HF who are refractory to loop diuretics alone (given 30 min before lasix)
metolazone
this drug requires close monitoring, can cause volume depletion and hypokalemia
metolazone
this class acts on the ascending LOH at the chloride pump (can potentially cause a 25-30% reduction in Na content of urine)
loops
this class is the most potent diuretic. can be used on pts with renal insufficiency that have failed thiazide
loops
this class can increase renal blood flow. Can relieve pulmonary congestion, decrease LV filling pressures before diuresis occurs
loops
class causes changes in urine ionic content: increases loss of Na, K ,water, and calcium
loops
this class is used for edema (heart failure), hypercalcemia, hyperkalemia, and acute renal failure
loops
adverse effects include: hyperuricemia, hyperglycemia, hypovolemia, hypotension, potassium and magnesium depletion, allergic reactions, and ototoxicity
loops
this drug is a synthetic steroid antagonist of aldosterone. It inhibits Na resorption and K secretion in collecting tubules
spironolactone
this drug is effective as an antiHTN, but limited use due to hyperkalemia
spironolactone
Can be used to treat primary and secondary aldosteronism. Also, it can blunt the potassium wasting tendencies of other diuretics
spironolactone
Adverse effects include gynocomastia, menstrual irregularities, hyperkalemia, and hyperchloremic metabolic acidosis
spironolactone
this drug directly inhibits sodium flux through the ion channels of the collecting tubule
triamterene
therapeutic uses: blunt K wasting tendencies of other diuretics, HTN. It is a weak diuretic alone, and is usually combined with thiazides
triamterene
adverse effects include hyperkalemia, hyperchloremic metabolic acidosis, and kidney stones
triamterene
all diuretics interact with this class of drug
NSAIDs
cholestyramine and sucralfate decrease the absorption of this diuretic
furosemide (loop)
Drug interactions include ACE I, digoxin, and diabetic medications
loop and thiazide diuretics
potassium sparing diuretics interact with this drug class
ACEI
this class blocks the conversion of angiotensin I to angiotensin II, resulting in vasodilation of vascular smooth muscle
ACEI
this class reduces PVR without a reflexive increase in CO, HR, or contractility
ACEI
this class stimulates the synthesis of vasodilatory prostaglandins. It decreases aldosterone, H20, and Na retention. Inhibits breakdown of bradykinin
ACEI
DO NOT USE in pregnancy or renovascular HTN
ACEI
Adverse effects: dry cough, altered taste, rashes, fever, hyperkalemia, elevations in SCr and BUN, hypotension and first dose syncope, and angioedema
ACEI
this class blocks the angiotensin II receptors competitively inhibiting angiotensin II binding to AT1 receptors. Blocks pressor and aldosterone-releasing effects causing vasodilation and decreased PVR
Angiotensin II antagonists
this class inhibits angiotensin II generated from all pathways, but DO NOT stimulate the synthesis of vasodilatory compounds
ARBs
This class is indicated for HTN and CHF. It is renal protective in patients with DM and may be considered first line
ARBs
DO not use in pregnancy or renal artery stenosis
ARBs
ADRs: rash, altered taste, hyperkalemia, elevated SCr BUN
ARB
this ARB reduces uric acid
losartan
this class causes reduction in HR, contractility, BP, and suppresses sympathetic nervous system activity
Beta blockers
therapeutic uses include ischemic heart disease, heart failure, dysrhythmias, and HTN
BB
this class of BB shows partial agonist activity- less reduction in resting HR, CO, and BP
intrinsic sympathomimetic activity (ISA)
contraindications include severe asthma, severe bradycardia, heart block, and overt HF
BB
Adverse effects include fatigue, lethargy, insomnia, depression, bronchoconstriction, cold extremities, sexual dysfunction, decrease HDL increase LDL, bradycardia. Abrupt withdrawal may precipitate MI
BB
block the inward movement of Ca by binding to L-type calcium, resulting in smooth muscle relaxation and arteriolar dilation
CCB
Therapeutic effects include coronary and peripheral vasodilation, negative inotropic and chronotropic effects. Alleviate coronary vasospasm
CCB
Used in HTN, ischemic heart disease, and dysrhythmias
CCB (dysrhythmias are non-dihydropyridinies only)
this drug is indicated for angina, HTN, supraventricular tachyarrhythmias, and migraines. Effects both cardiac and vascular smooth muscle
verapamil
this CCB effects cardiac and vascular smooth muscle but has less negative inotropic effects than verapamil, so fewer SEs
diltiazem
these CCBs have a great affinity for vascular cells IN THE PERIPHERY and does not effect cardiac contractility
dihydropyridines
these CCBs are beneficial for decreasing PVR but may induce reflex tachycardia
dihydropyridines
second generation dyhydropyridines- very effective and widely used
amlodipine and felodipine
this class of CCB can cause hypotension, dizziness and peripheral edema
dihydropyridines
this class of CCB can cause hypotension, dizziness, constipation, bradycardia, and exacerbation of HF
non-dihydropyridines
these drugs have no effect on blood sugar or lipids
CCB
this class is contraindicated in hypotension and immediate release in CV indications in adult pts due to cardiac ischemia
dihydropyridines
this class is contraindicated in severe bradycardia, hypotension, heart block, or overt HF. Careful in patients taking beta blockers (can cause AV block or heart failure)
non-dihydropyridines
this drug increases plasma digoxin levels
verapamil
this class lowers MAP by causing relaxation of both arterial and venous smooth muscle. Causes minimal changes in CO, renal blood flow, and GFR
alpha 1 receptor antagonists
this class is primarily used for BPH. Not used much for HTN (inferior to diuretics, postural hypotension, and first dose syncope)
alpha 1 receptor antagonists
caution in pts with poorly controlled angina w/o beta blocker and incontinence
alpha 1 receptor antagonists
ADRs: first dose syncope, dizziness, HA, postural hypotension, weakness, nausea, palpitations
alpha 1 receptor antagonists
alpha 2 agonist- causes inhibition of NE causing vasodilation. reduce activity of vasomotor center in the brian (reduced symp activity, vasodilation)
clonidine
this drug does not decrease renal BF or GFR- agent of choice for pts with chronic renal disease
clonidine
Indicated in HTN, drug withdrawl, and side effects associated with neuroleptics
clonidine
ADRs: dry mouth, sedation, depression, hypotension, sexual dysfunction, urinary retention, constipation, and dizziness. ABRUPT withdrawal can cause severe HTN
clonidine
analogue of levodopa- gets converted to methylnorepinepherine centrally decreases adrenergic outflow from the CNS. (acts as an alpha 2 agonist to decrease symp outflow)
methyldopa
agent of choice in HTN pts with chronic renal disease and pregnancy
methyldopa
this class directly acts on vascular smooth muscle, primary arterioles to decrease tone. Involves a decrease in calcium entry and mobilization of intracellular calcium stores
hydralazine
this is used for moderate to severe HTN- needs to be given with diuretic acid and a sympatholytic drug
hydralazine
ADRs include HA, nausea, anorexia, palpitations. Higher doses produce high incidence of symptoms that resemble lupus erythematosus
hydralazine
this class can be used as monotherapy or combo with diuretics or ARBs
aliskiren
this class inhibits generation of angiotensin I- preventing the formation of angiotensin II and reducing activation of all AT receptors
aliskiren
this drug does not inhibit bradykinin breakdown like ACEI
aliskiren
contraindicated in pregnancy- risk of fetal death or injury. DC ASAP (cat C in first trimester, D in second and third)
aliskiren
ADRs include angioedema, diarrhea, HA, cough, and an increase in SrCr
aliskiren
competitive inhibitor of CYP3A4. Interacts with atorvastatin and ketoconazole. Decreased efficacy of furosemide
aliskiren
DOC for HTN in pregnancy
methyldopa or labetalol (hydralazine if IV)
isolated systolic HTN
SBP > 140, DBP <90
goal treatment of iso systolic HTN
SBP< 140
DOC iso systolic HTN
thiazide diuretic
severely elevated BP without end organ damage
hypertensive urgency
severely elevated BP associated with acute and ongoing organ damage in the brain, kidneys, heart, eyes, or vascular system. (end organ damage; DBP usually >/= 130)
hypertensive emergency
Treat hypertensive urgency
(hours to days) clonidine, captopril, labetolol
treat hypertensive emergency
(minutes to hours) IV nitroprusside
this is a prodrug that decompensates to NO, causing vasodilation. Dilates both arteries AND veins (reduced TPR and venous return)
nitroprusside
this drug has an immediate onset of action (1-2 minutes). Can cause HA, dizziness, nausea, and palpitations
nitroprusside
metab of this drug results in cyanide production. Can administer thiosulfate to counteract
nitroprusside